Sales Support:

U.S.A:
+1-415-871-0703
UK:
+44-203-289-4040
The complete version of the Report will include the impact of the COVID-19, and anticipated change on the future outlook of the industry, by taking into the account the political, economic, social, and technological parameters.
1 Report Overview 1.1 Study Scope and Definition 1.2 Research Methodology 1.2.1 Methodology/Research Approach 1.2.2 Data Source 1.3 Key Market Segments 1.4 Players Covered: Ranking by Radiopharmaceutical Revenue 1.5 Market Analysis by Type 1.5.1 Global Radiopharmaceutical Market Size Growth Rate by Type: 2020 VS 2026 1.5.2 Actinium-225 1.5.3 Lutetium-177 1.5.4 Radium-223 1.5.5 Holmium-166 1.5.6 Other 1.6 Market by Application 1.6.1 Global Radiopharmaceutical Market Share by Application: 2021-2026 1.6.2 Oncology 1.6.3 Cardiology 1.6.4 Other 1.7 Coronavirus Disease 2019 (Covid-19) Impact Will Have a Severe Impact on Global Growth 1.7.1 Covid-19 Impact: Global GDP Growth, 2019, 2020 and 2021 Projections 1.7.2 Covid-19 Impact: Commodity Prices Indices 1.7.3 Covid-19 Impact: Global Major Government Policy 1.8 Study Objectives 1.9 Years Considered 2 Global Radiopharmaceutical Market Trends and Growth Strategy 2.1 Market Top Trends 2.2 Market Drivers 2.3 Market Challenges 2.4 Porter's Five Forces Analysis 2.5 Market Growth Strategy 2.6 SWOT Analysis 3 Global Radiopharmaceutical Market Players Profiles 3.1 Bracco Imaging 3.1.1 Bracco Imaging Company Profile 3.1.2 Bracco Imaging Radiopharmaceutical Product Specification 3.1.3 Bracco Imaging Radiopharmaceutical Production Capacity, Revenue, Price and Gross Margin (2015-2020) 3.2 GE Healthcare 3.2.1 GE Healthcare Company Profile 3.2.2 GE Healthcare Radiopharmaceutical Product Specification 3.2.3 GE Healthcare Radiopharmaceutical Production Capacity, Revenue, Price and Gross Margin (2015-2020) 3.3 Nordion 3.3.1 Nordion Company Profile 3.3.2 Nordion Radiopharmaceutical Product Specification 3.3.3 Nordion Radiopharmaceutical Production Capacity, Revenue, Price and Gross Margin (2015-2020) 3.4 Bayer 3.4.1 Bayer Company Profile 3.4.2 Bayer Radiopharmaceutical Product Specification 3.4.3 Bayer Radiopharmaceutical Production Capacity, Revenue, Price and Gross Margin (2015-2020) 3.5 IBA Group 3.5.1 IBA Group Company Profile 3.5.2 IBA Group Radiopharmaceutical Product Specification 3.5.3 IBA Group Radiopharmaceutical Production Capacity, Revenue, Price and Gross Margin (2015-2020) 3.6 Mallinckrodt 3.6.1 Mallinckrodt Company Profile 3.6.2 Mallinckrodt Radiopharmaceutical Product Specification 3.6.3 Mallinckrodt Radiopharmaceutical Production Capacity, Revenue, Price and Gross Margin (2015-2020) 3.7 Jubilant Pharma 3.7.1 Jubilant Pharma Company Profile 3.7.2 Jubilant Pharma Radiopharmaceutical Product Specification 3.7.3 Jubilant Pharma Radiopharmaceutical Production Capacity, Revenue, Price and Gross Margin (2015-2020) 3.8 Lantheus 3.8.1 Lantheus Company Profile 3.8.2 Lantheus Radiopharmaceutical Product Specification 3.8.3 Lantheus Radiopharmaceutical Production Capacity, Revenue, Price and Gross Margin (2015-2020) 3.9 Triad Isotopes 3.9.1 Triad Isotopes Company Profile 3.9.2 Triad Isotopes Radiopharmaceutical Product Specification 3.9.3 Triad Isotopes Radiopharmaceutical Production Capacity, Revenue, Price and Gross Margin (2015-2020) 3.10 China Isotope & Radiation 3.10.1 China Isotope & Radiation Company Profile 3.10.2 China Isotope & Radiation Radiopharmaceutical Product Specification 3.10.3 China Isotope & Radiation Radiopharmaceutical Production Capacity, Revenue, Price and Gross Margin (2015-2020) 3.11 Navidea 3.11.1 Navidea Company Profile 3.11.2 Navidea Radiopharmaceutical Product Specification 3.11.3 Navidea Radiopharmaceutical Production Capacity, Revenue, Price and Gross Margin (2015-2020) 3.12 Eli Lilly 3.12.1 Eli Lilly Company Profile 3.12.2 Eli Lilly Radiopharmaceutical Product Specification 3.12.3 Eli Lilly Radiopharmaceutical Production Capacity, Revenue, Price and Gross Margin (2015-2020) 3.13 Dongcheng 3.13.1 Dongcheng Company Profile 3.13.2 Dongcheng Radiopharmaceutical Product Specification 3.13.3 Dongcheng Radiopharmaceutical Production Capacity, Revenue, Price and Gross Margin (2015-2020) 3.14 Advanced Accelerator Applications 3.14.1 Advanced Accelerator Applications Company Profile 3.14.2 Advanced Accelerator Applications Radiopharmaceutical Product Specification 3.14.3 Advanced Accelerator Applications Radiopharmaceutical Production Capacity, Revenue, Price and Gross Margin (2015-2020) 3.15 SIEMENS 3.15.1 SIEMENS Company Profile 3.15.2 SIEMENS Radiopharmaceutical Product Specification 3.15.3 SIEMENS Radiopharmaceutical Production Capacity, Revenue, Price and Gross Margin (2015-2020) 4 Global Radiopharmaceutical Market Competition by Market Players 4.1 Global Radiopharmaceutical Production Capacity Market Share by Market Players (2015-2020) 4.2 Global Radiopharmaceutical Revenue Market Share by Market Players (2015-2020) 4.3 Global Radiopharmaceutical Average Price by Market Players (2015-2020) 5 Global Radiopharmaceutical Production by Regions (2015-2020) 5.1 North America 5.1.1 North America Radiopharmaceutical Market Size (2015-2020) 5.1.2 Radiopharmaceutical Key Players in North America (2015-2020) 5.1.3 North America Radiopharmaceutical Market Size by Type (2015-2020) 5.1.4 North America Radiopharmaceutical Market Size by Application (2015-2020) 5.2 East Asia 5.2.1 East Asia Radiopharmaceutical Market Size (2015-2020) 5.2.2 Radiopharmaceutical Key Players in East Asia (2015-2020) 5.2.3 East Asia Radiopharmaceutical Market Size by Type (2015-2020) 5.2.4 East Asia Radiopharmaceutical Market Size by Application (2015-2020) 5.3 Europe 5.3.1 Europe Radiopharmaceutical Market Size (2015-2020) 5.3.2 Radiopharmaceutical Key Players in Europe (2015-2020) 5.3.3 Europe Radiopharmaceutical Market Size by Type (2015-2020) 5.3.4 Europe Radiopharmaceutical Market Size by Application (2015-2020) 5.4 South Asia 5.4.1 South Asia Radiopharmaceutical Market Size (2015-2020) 5.4.2 Radiopharmaceutical Key Players in South Asia (2015-2020) 5.4.3 South Asia Radiopharmaceutical Market Size by Type (2015-2020) 5.4.4 South Asia Radiopharmaceutical Market Size by Application (2015-2020) 5.5 Southeast Asia 5.5.1 Southeast Asia Radiopharmaceutical Market Size (2015-2020) 5.5.2 Radiopharmaceutical Key Players in Southeast Asia (2015-2020) 5.5.3 Southeast Asia Radiopharmaceutical Market Size by Type (2015-2020) 5.5.4 Southeast Asia Radiopharmaceutical Market Size by Application (2015-2020) 5.6 Middle East 5.6.1 Middle East Radiopharmaceutical Market Size (2015-2020) 5.6.2 Radiopharmaceutical Key Players in Middle East (2015-2020) 5.6.3 Middle East Radiopharmaceutical Market Size by Type (2015-2020) 5.6.4 Middle East Radiopharmaceutical Market Size by Application (2015-2020) 5.7 Africa 5.7.1 Africa Radiopharmaceutical Market Size (2015-2020) 5.7.2 Radiopharmaceutical Key Players in Africa (2015-2020) 5.7.3 Africa Radiopharmaceutical Market Size by Type (2015-2020) 5.7.4 Africa Radiopharmaceutical Market Size by Application (2015-2020) 5.8 Oceania 5.8.1 Oceania Radiopharmaceutical Market Size (2015-2020) 5.8.2 Radiopharmaceutical Key Players in Oceania (2015-2020) 5.8.3 Oceania Radiopharmaceutical Market Size by Type (2015-2020) 5.8.4 Oceania Radiopharmaceutical Market Size by Application (2015-2020) 5.9 South America 5.9.1 South America Radiopharmaceutical Market Size (2015-2020) 5.9.2 Radiopharmaceutical Key Players in South America (2015-2020) 5.9.3 South America Radiopharmaceutical Market Size by Type (2015-2020) 5.9.4 South America Radiopharmaceutical Market Size by Application (2015-2020) 5.10 Rest of the World 5.10.1 Rest of the World Radiopharmaceutical Market Size (2015-2020) 5.10.2 Radiopharmaceutical Key Players in Rest of the World (2015-2020) 5.10.3 Rest of the World Radiopharmaceutical Market Size by Type (2015-2020) 5.10.4 Rest of the World Radiopharmaceutical Market Size by Application (2015-2020) 6 Global Radiopharmaceutical Consumption by Region (2015-2020) 6.1 North America 6.1.1 North America Radiopharmaceutical Consumption by Countries 6.1.2 United States 6.1.3 Canada 6.1.4 Mexico 6.2 East Asia 6.2.1 East Asia Radiopharmaceutical Consumption by Countries 6.2.2 China 6.2.3 Japan 6.2.4 South Korea 6.3 Europe 6.3.1 Europe Radiopharmaceutical Consumption by Countries 6.3.2 Germany 6.3.3 United Kingdom 6.3.4 France 6.3.5 Italy 6.3.6 Russia 6.3.7 Spain 6.3.8 Netherlands 6.3.9 Switzerland 6.3.10 Poland 6.4 South Asia 6.4.1 South Asia Radiopharmaceutical Consumption by Countries 6.4.2 India 6.5 Southeast Asia 6.5.1 Southeast Asia Radiopharmaceutical Consumption by Countries 6.5.2 Indonesia 6.5.3 Thailand 6.5.4 Singapore 6.5.5 Malaysia 6.5.6 Philippines 6.6 Middle East 6.6.1 Middle East Radiopharmaceutical Consumption by Countries 6.6.2 Turkey 6.6.3 Saudi Arabia 6.6.4 Iran 6.6.5 United Arab Emirates 6.7 Africa 6.7.1 Africa Radiopharmaceutical Consumption by Countries 6.7.2 Nigeria 6.7.3 South Africa 6.8 Oceania 6.8.1 Oceania Radiopharmaceutical Consumption by Countries 6.8.2 Australia 6.9 South America 6.9.1 South America Radiopharmaceutical Consumption by Countries 6.9.2 Brazil 6.9.3 Argentina 6.10 Rest of the World 6.10.1 Rest of the World Radiopharmaceutical Consumption by Countries 7 Global Radiopharmaceutical Production Forecast by Regions (2021-2026) 7.1 Global Forecasted Production of Radiopharmaceutical (2021-2026) 7.2 Global Forecasted Revenue of Radiopharmaceutical (2021-2026) 7.3 Global Forecasted Price of Radiopharmaceutical (2021-2026) 7.4 Global Forecasted Production of Radiopharmaceutical by Region (2021-2026) 7.4.1 North America Radiopharmaceutical Production, Revenue Forecast (2021-2026) 7.4.2 East Asia Radiopharmaceutical Production, Revenue Forecast (2021-2026) 7.4.3 Europe Radiopharmaceutical Production, Revenue Forecast (2021-2026) 7.4.4 South Asia Radiopharmaceutical Production, Revenue Forecast (2021-2026) 7.4.5 Southeast Asia Radiopharmaceutical Production, Revenue Forecast (2021-2026) 7.4.6 Middle East Radiopharmaceutical Production, Revenue Forecast (2021-2026) 7.4.7 Africa Radiopharmaceutical Production, Revenue Forecast (2021-2026) 7.4.8 Oceania Radiopharmaceutical Production, Revenue Forecast (2021-2026) 7.4.9 South America Radiopharmaceutical Production, Revenue Forecast (2021-2026) 7.4.10 Rest of the World Radiopharmaceutical Production, Revenue Forecast (2021-2026) 7.5 Forecast by Type and by Application (2021-2026) 7.5.1 Global Sales Volume, Sales Revenue and Sales Price Forecast by Type (2021-2026) 7.5.2 Global Forecasted Consumption of Radiopharmaceutical by Application (2021-2026) 8 Global Radiopharmaceutical Consumption Forecast by Regions (2021-2026) 8.1 North America Forecasted Consumption of Radiopharmaceutical by Country 8.2 East Asia Market Forecasted Consumption of Radiopharmaceutical by Country 8.3 Europe Market Forecasted Consumption of Radiopharmaceutical by Countriy 8.4 South Asia Forecasted Consumption of Radiopharmaceutical by Country 8.5 Southeast Asia Forecasted Consumption of Radiopharmaceutical by Country 8.6 Middle East Forecasted Consumption of Radiopharmaceutical by Country 8.7 Africa Forecasted Consumption of Radiopharmaceutical by Country 8.8 Oceania Forecasted Consumption of Radiopharmaceutical by Country 8.9 South America Forecasted Consumption of Radiopharmaceutical by Country 8.10 Rest of the world Forecasted Consumption of Radiopharmaceutical by Country 9 Global Radiopharmaceutical Sales by Type (2015-2026) 9.1 Global Radiopharmaceutical Historic Market Size by Type (2015-2020) 9.2 Global Radiopharmaceutical Forecasted Market Size by Type (2021-2026) 10 Global Radiopharmaceutical Consumption by Application (2015-2026) 10.1 Global Radiopharmaceutical Historic Market Size by Application (2015-2020) 10.2 Global Radiopharmaceutical Forecasted Market Size by Application (2021-2026) 11 Global Radiopharmaceutical Manufacturing Cost Analysis 11.1 Radiopharmaceutical Key Raw Materials Analysis 11.1.1 Key Raw Materials 11.2 Proportion of Manufacturing Cost Structure 11.3 Manufacturing Process Analysis of Radiopharmaceutical 12 Global Radiopharmaceutical Marketing Channel, Distributors, Customers and Supply Chain 12.1 Marketing Channel 12.2 Radiopharmaceutical Distributors List 12.3 Radiopharmaceutical Customers 12.4 Radiopharmaceutical Supply Chain Analysis 13 Analyst's Viewpoints/Conclusions 14 Disclaimer
Price : US$ 2,900 | Date : Nov 2020 |
Category : Medical Devices | Pages : 125 |
Price : US$ 2,450 | Date : Aug 2020 |
Category : Healthcare and Pharmaceuticals | Pages : 146 |
Price : US$ 3,000 | Date : Sep 2020 |
Category : Medical Devices | Pages : 91 |
Price : US$ 3,480 | Date : Feb 2019 |
Category : Healthcare and Pharmaceuticals | Pages : 138 |
Price : US$ 4,480 | Date : Oct 2017 |
Category : Healthcare and Pharmaceuticals | Pages : 124 |
We will be happy to help you find what you need. Please call us or write to us: